Immunosuppression facilitates the reactivation of latent papillomavirus infections.
about
The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in AfricaHuman Papillomaviruses; Epithelial Tropisms, and the Development of NeoplasiaRole of Ultraviolet Radiation in Papillomavirus-Induced DiseaseStrain-specific properties and T cells regulate the susceptibility to papilloma induction by Mus musculus papillomavirus 1HPV clearance and the neglected role of stochasticitySpontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 InfectionImmunologic Control of Mus musculus Papillomavirus Type 1.Independent Pre-Transplant Recipient Cancer Risk Factors after Kidney Transplantation and the Utility of G-Chart Analysis for Clinical Process Control.Pathophysiology of ocular surface squamous neoplasiaEvidence of disrupted high-risk human papillomavirus DNA in morphologically normal cervices of older women.Unilateral Conjunctival in situ Squamous Carcinoma with Bilateral Conjunctival Chlorpromazine-Induced Secondary Melanosis Masquerading as in situ and Invasive Melanoma.Human papillomavirus molecular biology and disease association.Model systems of human papillomavirus-associated disease.Reactivation of Latent HPV Infections After Renal Transplantation.Cervicovaginal HPV infection in female renal transplant recipients: an observational, self-sampling based, cohort study.Why Human Papillomavirus Acute Infections Matter.Natural History of HPV Infection across the Lifespan: Role of Viral Latency.Prevalence of tonsillar human papillomavirus infections in Denmark.Carcinogenic human papillomavirus infection.Rodent Papillomaviruses.Cervical HPV prevalence and genotype distribution in immunosuppressed Danish women.Redetection of Human Papillomavirus Type 16 Infections of the Cervix in Mid-Adult Life.Cutaneous Papillomaviruses and Non-melanoma Skin Cancer: Causal Agents or Innocent Bystanders?
P2860
Q26799584-C72729F5-DF9B-44A6-AD80-C403136EF5A0Q26801768-0F336E41-9C69-439E-9001-9157A8E4E67AQ27313673-5A60B526-CDC8-40CB-930F-99B1ACFC1C17Q27324289-6851F3A9-F574-4B7A-97B1-8280D128A29DQ28652424-B7D0BB2B-9F28-4B04-9F8C-52149F84D431Q33907700-DD3EBBCD-BBB0-48B6-8912-9E02BD5243D8Q35818624-EBC2A2C0-01AF-45EA-8F1A-F05148F8CDD2Q36072514-FD13BFA7-C2EC-434A-BA59-4C223121DC57Q36501666-9BDE1730-ECD5-48B3-92A6-A6D0103F60BEQ36579661-83E2E2F3-E672-4478-A5C3-63BDBCA17ED8Q36842130-851346EC-C97D-41FC-8E20-F3C838707DE8Q37257349-31156349-BD2B-4BC1-B163-7AB50B501099Q38604326-4318233C-1174-4C09-98B2-9FA18C2016BBQ40397729-15207250-E205-4A62-BCB7-ADDCFE38C096Q41444452-CDB40ABF-5271-417B-91E7-ECB532B66040Q41921051-4CF86F5C-00D2-4E96-84A1-A39B176E0849Q41932990-4E29C56F-7AF0-4C9E-B55F-5F97BD849ADEQ42200672-50103DBE-3EF1-4561-BC85-B85196426193Q44863515-EE952D26-EAA1-4C06-8E8D-3FB633795C6EQ46251800-DBB59E36-1938-479F-B0F6-9E1C1BB6A046Q47212161-679B9BA6-C486-4C35-BE03-22254212C5AFQ49884632-49638BBC-B29A-47F1-BE46-55E689C2C228Q55054189-5BBE4327-2041-4239-B4CF-A4D2D8ACCDF0
P2860
Immunosuppression facilitates the reactivation of latent papillomavirus infections.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunosuppression facilitates the reactivation of latent papillomavirus infections.
@en
Immunosuppression facilitates the reactivation of latent papillomavirus infections.
@nl
type
label
Immunosuppression facilitates the reactivation of latent papillomavirus infections.
@en
Immunosuppression facilitates the reactivation of latent papillomavirus infections.
@nl
prefLabel
Immunosuppression facilitates the reactivation of latent papillomavirus infections.
@en
Immunosuppression facilitates the reactivation of latent papillomavirus infections.
@nl
P2093
P2860
P356
P1433
P1476
Immunosuppression facilitates the reactivation of latent papillomavirus infections.
@en
P2093
G A Maglennon
P B McIntosh
P2860
P304
P356
10.1128/JVI.02589-13
P407
P577
2013-10-30T00:00:00Z